The Impact of COVID-19 is included in Brain Cancer Diagnostic Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Brain Cancer Diagnostic Trends and Forecast
The future of the global brain cancer diagnostic market looks promising with opportunities in the hospital, specialty clinic, diagnostic center & research institute, ambulatory surgical center markets. The global brain cancer diagnostic market is expected to reach an estimated $9.3 billion by 2030 with a CAGR of 23.7% from 2024 to 2030. The major drivers for this market are the increasing cases of brain cancer, growing awareness towards early diagnosis for brain cancer, and innovations in drug delivery system related to brain cancer cells.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Brain Cancer Diagnostic by Segment
The study includes a forecast for the global brain cancer diagnostic by test type, cancer type, age group, end use, and region.
Brain Cancer Diagnostic Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:
• Imaging Test
• Biopsy
• Lumber Puncture
• Molecular Testing
• Electroencephalography
• Others
Brain Cancer Diagnostic Market by Cancer Type [Shipment Analysis by Value from 2018 to 2030]:
• Acoustic Neuroma
• Astrocytomas
• Glioblastoma Multiforme
• Meningiomas
• Oligodendroglioma
• Others
Brain Cancer Diagnostic Market by Age Group [Shipment Analysis by Value from 2018 to 2030]:
• Children
• Adult
• Geriatic
Brain Cancer Diagnostic Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Hospitals
• Specialty Clinics
• Diagnostic Centers & Research Institutes
• Ambulatory Surgical Centers
• Others
Brain Cancer Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Brain Cancer Diagnostic Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies brain cancer diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the brain cancer diagnostic companies profiled in this report include-
• Thermo Fisher Scientific
• Siemens Healthcare Diagnostics
• Hologic
• Nantomics
• GE Healthcare
• Nihon Kohden
• Canon
• Fujifilm Holdings
Brain Cancer Diagnostic Market Insights
Lucintel forecasts that glioblastoma multiforme will remain the largest segment due to the etiological trends of lifestyle, genetic factors, and improved diagnostic systems.
Within this market, hospitals is expected to witness highest growth over the forecast period due to increasing prevelance of brain cancer, improvement in the hospital infrastructure, and rising investments and funding in cancer daignostics.
North America will remain the largest segment due to increasing research and development activities and improved imaging techniques in the region.
Features of the Global Brain Cancer Diagnostic Market
Market Size Estimates: Brain cancer diagnostic market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Brain cancer diagnostic market size by various segments, such as by test type, cancer type, age group, end use, and region in terms of ($B).
Regional Analysis: Brain cancer diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different test types, cancer types, age groups, end uses, and regions for the brain cancer diagnostic market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the brain cancer diagnostic market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the brain cancer diagnostic market size?
Answer: The global brain cancer diagnostic market is expected to reach an estimated $9.3 billion by 2030.
Q.2 What is the growth forecast for brain cancer diagnostic market?
Answer: The global brain cancer diagnostic market is expected to grow with a CAGR of 23.7% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the brain cancer diagnostic market?
Answer: The major drivers for this market are the increasing cases of brain cancer, growing awareness towards early diagnosis for brain cancer, and innovations in drug delivery system related to brain cancer cells.
Q4. What are the major segments for brain cancer diagnostic market?
Answer: The future of the brain cancer diagnostic market looks promising with opportunities in the hospital, specialty clinic, diagnostic center & research institute, ambulatory surgical center markets.
Q5. Who are the key brain cancer diagnostic market companies?
Answer: Some of the key brain cancer diagnostic companies are as follows:
• Thermo Fisher Scientific
• Siemens Healthcare Diagnostics
• Hologic
• Nantomics
• GE Healthcare
• Nihon Kohden
• Canon
• Fujifilm Holdings
Q6. Which brain cancer diagnostic market segment will be the largest in future?
Answer: Lucintel forecasts that glioblastoma multiforme will remain the largest segment due to the etiological trends of lifestyle, genetic factors, and improved diagnostic systems.
Q7. In brain cancer diagnostic market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest segment due to increasing research and development activities and improved imaging techniques in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the brain cancer diagnostic market by test type (imaging test, biopsy, lumber puncture, molecular testing, electroencephalography, and others), cancer type (acoustic neuroma, astrocytomas, glioblastoma multiforme, meningiomas, oligodendroglioma, and others), age group (children, adult, and geriatic), end use (hospitals, specialty clinics, diagnostic centers & research institutes, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Brain Cancer Diagnostic Market, Brain Cancer Diagnostic Market Size, Brain Cancer Diagnostic Market Growth, Brain Cancer Diagnostic Market Analysis, Brain Cancer Diagnostic Market Report, Brain Cancer Diagnostic Market Share, Brain Cancer Diagnostic Market Trends, Brain Cancer Diagnostic Market Forecast, Brain Cancer Diagnostic Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Brain Cancer Diagnostic Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Brain Cancer Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Brain Cancer Diagnostic Market by Test Type
3.3.1: Imaging Test
3.3.2: Biopsy
3.3.3: Lumber Puncture
3.3.4: Molecular Testing
3.3.5: Electroencephalography
3.3.6: Others
3.4: Global Brain Cancer Diagnostic Market by Cancer Type
3.4.1: Acoustic Neuroma
3.4.2: Astrocytomas
3.4.3: Glioblastoma Multiforme
3.4.4: Meningiomas
3.4.5: Oligodendroglioma
3.4.6: Others
3.5: Global Brain Cancer Diagnostic Market by Age Group
3.5.1: Children
3.5.2: Adult
3.5.3: Geriatic
3.6: Global Brain Cancer Diagnostic Market by End Use
3.6.1: Hospitals
3.6.2: Specialty Clinics
3.6.3: Diagnostic Centers & Research Institutes
3.6.4: Ambulatory Surgical Centers
3.6.5: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Brain Cancer Diagnostic Market by Region
4.2: North American Brain Cancer Diagnostic Market
4.2.2: North American Brain Cancer Diagnostic Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others
4.3: European Brain Cancer Diagnostic Market
4.3.1: European Brain Cancer Diagnostic Market by Cancer Type: Acoustic Neuroma, Astrocytomas, Glioblastoma Multiforme, Meningiomas, Oligodendroglioma, and Others
4.3.2: European Brain Cancer Diagnostic Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others
4.4: APAC Brain Cancer Diagnostic Market
4.4.1: APAC Brain Cancer Diagnostic Market by Cancer Type: Acoustic Neuroma, Astrocytomas, Glioblastoma Multiforme, Meningiomas, Oligodendroglioma, and Others
4.4.2: APAC Brain Cancer Diagnostic Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others
4.5: ROW Brain Cancer Diagnostic Market
4.5.1: ROW Brain Cancer Diagnostic Market by Cancer Type: Acoustic Neuroma, Astrocytomas, Glioblastoma Multiforme, Meningiomas, Oligodendroglioma, and Others
4.5.2: ROW Brain Cancer Diagnostic Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Brain Cancer Diagnostic Market by Test Type
6.1.2: Growth Opportunities for the Global Brain Cancer Diagnostic Market by Cancer Type
6.1.3: Growth Opportunities for the Global Brain Cancer Diagnostic Market by Age Group
6.1.4: Growth Opportunities for the Global Brain Cancer Diagnostic Market by End Use
6.1.5: Growth Opportunities for the Global Brain Cancer Diagnostic Market by Region
6.2: Emerging Trends in the Global Brain Cancer Diagnostic Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Brain Cancer Diagnostic Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Brain Cancer Diagnostic Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Thermo Fisher Scientific
7.2: Siemens Healthcare Diagnostics
7.3: Hologic
7.4: NantOmics
7.5: GE Healthcare
7.6: NIHON KOHDEN
7.7: Canon
7.8: FUJIFILM Holdings
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Brain Cancer Diagnostic Market Report.